Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy

  1. Manegold, C.
  2. Adjei, A.
  3. Bussolino, F.
  4. Cappuzzo, F.
  5. Crino, L.
  6. Dziadziuszko, R.
  7. Ettinger, D.
  8. Fennell, D.
  9. Kerr, K.
  10. Le Chevalier, T.
  11. Leighl, N.
  12. Papotti, M.
  13. Paz-Ares, L.
  14. Pérol, M.
  15. Peters, S.
  16. Pirker, R.
  17. Quoix, E.
  18. Reck, M.
  19. Smit, E.
  20. Vokes, E.
  21. Van Zandwijk, N.
  22. Zhou, C.
Revue:
ESMO Open

ISSN: 2059-7029

Année de publication: 2016

Volumen: 1

Número: 6

Type: Révision

DOI: 10.1136/ESMOOPEN-2016-000118 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus